Feb 27 (Reuters) - Europe's medicines regulator on Friday recommended granting marketing authorisation to mCombriax, making Moderna's MRNA.O messenger RNA vaccine the world's first combined shot for people aged 50 and older against COVID and seasonal influenza in a single dose.
(Reporting by Sri Hari N S in Bengaluru; Editing by Vijay Kishore)
((srihari.ns@thomsonreuters.com))